These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6280742)

  • 21. Vinca-23-oyl amino acid derivatives: as new anticancer agents (review).
    Bhushana Rao KS; Collard MP; Trouet A
    Anticancer Res; 1985; 5(4):379-86. PubMed ID: 3898995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
    Kris MG; Gralla RJ; Kelsen DP; Casper ES; Burke MT; Fiore JJ; Cibas IR; Heelan RT
    Chest; 1985 Mar; 87(3):368-72. PubMed ID: 2982552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).
    Dyke RW; Nelson RL
    Cancer Treat Rev; 1977 Jun; 4(2):135-42. PubMed ID: 329987
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro.
    Jordan MA; Himes RH; Wilson L
    Cancer Res; 1985 Jun; 45(6):2741-7. PubMed ID: 3986806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS
    Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
    [No Abstract]   [Full Text] [Related]  

  • 26. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
    Luedke SL; Luedke DW; Petruska P; Broun GO; Reed G; Leavitt J
    Cancer Treat Rep; 1982 Jun; 66(6):1409-11. PubMed ID: 7083243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study.
    Miller TP; Weick JK; Grozea PN; Carlin DA
    Cancer Treat Rep; 1982 Mar; 66(3):553-6. PubMed ID: 6277487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung.
    Bernath AM; Cohen MH; Ihde DC; Fossieck BE; Matthews MJ; Minna JD
    Cancer Treat Rep; 1976 Sep; 60(9):1393-4. PubMed ID: 189924
    [No Abstract]   [Full Text] [Related]  

  • 31. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitomycin-associated lung disease.
    Gunstream SR; Seidenfeld JJ; Sobonya RE; McMahon LJ
    Cancer Treat Rep; 1983 Mar; 67(3):301-4. PubMed ID: 6187452
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
    König HJ; Arnold E; Walter M; Sander U
    Fortschr Med; 1984 Sep; 102(33):811-4. PubMed ID: 6090286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
    Niederle N; Schütte J; Schmidt CG; Seeber S
    Cancer Treat Rep; 1984 May; 68(5):791-2. PubMed ID: 6327037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New agents in non-small cell lung cancer.
    Joss RA; Cavalli F; Goldhirsch A; Mermillod B; Brunner KW
    Cancer Treat Rev; 1984 Sep; 11(3):205-36. PubMed ID: 6395953
    [No Abstract]   [Full Text] [Related]  

  • 36. Carcinoma metastatic to the anterior ocular segment: response to chemotherapy.
    Sierocki JS; Charles NC; Schafrank M; Wittes RE
    Cancer; 1980 May; 45(10):2521-3. PubMed ID: 6247053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinoma.
    Smith IE; Coombes RC; Evans BD; Ford HT; Gazet JC; Gordon C; McKinna JA; Powles TJ
    Eur J Cancer (1965); 1980; Suppl 1():271-3. PubMed ID: 7032939
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
    Drings P; Manke HG
    Strahlentherapie; 1985 Mar; 161(3):131-3. PubMed ID: 2983459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
    Furnas BE; Williams SD; Einhorn LH; Cobleigh MA
    Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro chemosensitivity of human lung cancer for vindesine.
    De Vries EG; Meijer C; Mulder NH; Postmus PE
    Eur J Cancer Clin Oncol; 1987 Jan; 23(1):55-60. PubMed ID: 3036536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.